{"id":79796,"date":"2023-04-06T09:20:33","date_gmt":"2023-04-06T08:20:33","guid":{"rendered":"https:\/\/www.iispv.cat\/ajut\/approaches-to-increase-equitable-access-to-and-delivery-of-quality-of-care-with-bispecific-antibodies-for-patients-with-multiple-myeloma\/"},"modified":"2023-04-06T09:22:06","modified_gmt":"2023-04-06T08:22:06","slug":"approaches-to-increase-equitable-access-to-and-delivery-of-quality-of-care-with-bispecific-antibodies-for-patients-with-multiple-myeloma","status":"publish","type":"ajut","link":"https:\/\/www.iispv.cat\/en\/ajut\/approaches-to-increase-equitable-access-to-and-delivery-of-quality-of-care-with-bispecific-antibodies-for-patients-with-multiple-myeloma\/","title":{"rendered":"APPROACHES TO INCREASE EQUITABLE ACCESS TO AND DELIVERY OF QUALITY OF CARE WITH BISPECIFIC ANTIBODIES FOR PATIENTS WITH MULTIPLE MYELOMA"},"content":{"rendered":"","protected":false},"menu_order":0,"template":"","categoria_ajuts":[1170],"entitat_ajuts":[1207],"class_list":["post-79796","ajut","type-ajut","status-publish","hentry","categoria_ajuts-suport-a-la-recerca-en","entitat_ajuts-pfizer-s-a-en"],"_links":{"self":[{"href":"https:\/\/www.iispv.cat\/en\/wp-json\/wp\/v2\/ajut\/79796","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iispv.cat\/en\/wp-json\/wp\/v2\/ajut"}],"about":[{"href":"https:\/\/www.iispv.cat\/en\/wp-json\/wp\/v2\/types\/ajut"}],"wp:attachment":[{"href":"https:\/\/www.iispv.cat\/en\/wp-json\/wp\/v2\/media?parent=79796"}],"wp:term":[{"taxonomy":"categoria_ajuts","embeddable":true,"href":"https:\/\/www.iispv.cat\/en\/wp-json\/wp\/v2\/categoria_ajuts?post=79796"},{"taxonomy":"entitat_ajuts","embeddable":true,"href":"https:\/\/www.iispv.cat\/en\/wp-json\/wp\/v2\/entitat_ajuts?post=79796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}